GALNT13 |
|||
| MBS8577625-01mL | MyBiosource | 0.1mL | EUR 345 |
GALNT13 |
|||
| MBS8577625-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
GALNT13 |
|||
| MBS8577625-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
GALNT13 |
|||
| MBS8577625-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
GALNT13 |
|||
| MBS8577625-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
GALNT13 |
|||
| MBS8562931-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
GALNT13 |
|||
| MBS8562931-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
GALNT13 |
|||
| MBS8562931-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
GALNT13 |
|||
| MBS8562931-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
GALNT13 |
|||
| MBS8562931-02mL | MyBiosource | 0.2mL | EUR 345 |
GALNT13 Peptide |
|||
| MBS3234797-01mg | MyBiosource | 0.1mg | EUR 180 |
GALNT13 Peptide |
|||
| MBS3234797-5x01mg | MyBiosource | 5x0.1mg | EUR 730 |
GALNT13 Antibody |
|||
| GWB-MR827H | GenWay Biotech | 50ug | Ask for price |
GALNT13 Antibody |
|||
| E310792 | EnoGene | 200ul | EUR 275 |
|
Description: Available in various conjugation types. |
|||
GALNT13 antibody |
|||
| 70R-7449 | Fitzgerald Industries International | 50 ug | Ask for price |
Rat GALNT13 siRNA |
|||
| 20-abx917524 | Abbexa |
|
|
GALNT13 siRNA (Rat) |
|||
| MBS8207532-15nmol | MyBiosource | 15nmol | EUR 405 |
GALNT13 siRNA (Rat) |
|||
| MBS8207532-30nmol | MyBiosource | 30nmol | EUR 565 |
GALNT13 siRNA (Rat) |
|||
| MBS8207532-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
GALNT13 cDNA Clone |
|||
| MBS1271435-001mgPlasmid02mLGlycerolStock | MyBiosource | 0.01mgPlasmid+0.2mLGlycerol-Stock | EUR 330 |
GALNT13 cDNA Clone |
|||
| MBS1271435-5x001mgPlasmid5x02mLGlycerolStock | MyBiosource | 5x0.01mgPlasmid+5x0.2mLGlycerol-Stock | EUR 1430 |
Mouse GALNT13 siRNA |
|||
| 20-abx917525 | Abbexa |
|
|
Human GALNT13 siRNA |
|||
| 20-abx902081 | Abbexa |
|
|
GALNT13 siRNA (Mouse) |
|||
| MBS8201911-15nmol | MyBiosource | 15nmol | EUR 405 |
GALNT13 siRNA (Mouse) |
|||
| MBS8201911-30nmol | MyBiosource | 30nmol | EUR 565 |
GALNT13 siRNA (Mouse) |
|||
| MBS8201911-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
GALNT13 siRNA (Human) |
|||
| MBS8241332-15nmol | MyBiosource | 15nmol | EUR 405 |
GALNT13 siRNA (Human) |
|||
| MBS8241332-30nmol | MyBiosource | 30nmol | EUR 565 |
GALNT13 siRNA (Human) |
|||
| MBS8241332-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
GALNT13 cloning plasmid |
|||
| CSB-CL816873HU-10ug | Cusabio | 10ug | EUR 451.2 |
|
Description: A cloning plasmid for the GALNT13 gene. |
|||
GALNT13 Antibody (Center) |
|||
| MBS9202631-008mL | MyBiosource | 0.08mL | EUR 210 |
GALNT13 Antibody (Center) |
|||
| MBS9202631-04mL | MyBiosource | 0.4mL | EUR 430 |
GALNT13 Antibody (Center) |
|||
| MBS9202631-5x04mL | MyBiosource | 5x0.4mL | EUR 1910 |
GALNT13 Polyclonal Antibody |
|||
| MBS9234690-01mL | MyBiosource | 0.1mL | EUR 415 |
GALNT13 Polyclonal Antibody |
|||
| MBS9234690-5x01mL | MyBiosource | 5x0.1mL | EUR 1841 |
Rat GALNT13 shRNA Plasmid |
|||
| 20-abx989647 | Abbexa |
|
|
Mouse GALNT13 shRNA Plasmid |
|||
| 20-abx983132 | Abbexa |
|
|
Human GALNT13 shRNA Plasmid |
|||
| 20-abx964387 | Abbexa |
|
|
Human GALNT13 Protein Lysate |
|||
| MBS8412086-002mg | MyBiosource | 0.02mg | EUR 365 |
Human GALNT13 Protein Lysate |
|||
| MBS8412086-5x002mg | MyBiosource | 5x0.02mg | EUR 1410 |
GALNT13 Recombinant Protein (Rat) |
|||
| RP202163 | ABM | 100 ug | Ask for price |
AAP50222-100UG - GALNT13 Peptide |
|||
| AAP50222-100UG | Aviva Systems Biology | 100ug | EUR 99 |
GALNT13 Recombinant Protein (Human) |
|||
| RP039385 | ABM | 100 ug | Ask for price |
GALNT13 Recombinant Protein (Mouse) |
|||
| RP135824 | ABM | 100 ug | Ask for price |
GALNT13 (untagged) - Human polypeptide N-acetylgalactosaminyltransferase 13 (GALNT13), transcript variant 2 |
|||
| SC336796 | Origene Technologies GmbH | 10 µg | Ask for price |
GALNT13 (NM_052917) Human Recombinant Protein |
|||
| E45H35581M5 | EnoGene | 20 ug | EUR 785.42 |
Galnt13 (NM_173030) Mouse Recombinant Protein |
|||
| E45M43983M5 | EnoGene | 20 ug | EUR 1924.54 |
GALNT13 (NM_052917) Human Recombinant Protein |
|||
| PROTQ8IUC8 | BosterBio | 20ug | EUR 1249 |
|
Description: Recombinant protein of human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13) (GALNT13) |
|||
Galnt13 ORF Vector (Rat) (pORF) |
|||
| ORF067389 | ABM | 1.0 ug DNA | EUR 607.2 |
GALNT13 ORF Vector (Human) (pORF) |
|||
| ORF013129 | ABM | 1.0 ug DNA | EUR 424.8 |
Galnt13 ORF Vector (Mouse) (pORF) |
|||
| ORF045276 | ABM | 1.0 ug DNA | EUR 607.2 |
Mouse Galnt13 qPCR Primer Pair |
|||
| QM69298S | Beyotime Biotech Inc | 200 Tests | Ask for price |
Human GALNT13 qPCR Primer Pair |
|||
| QH59609S | Beyotime Biotech Inc | 200 Tests | Ask for price |
Human GALNT13 knockout cell line |
|||
| ABC-KH5880 | AcceGen | 1 vial | Ask for price |
|
Description: Human GALNT13 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
|||
Human GALNT13 knockdown cell line |
|||
| ABC-KD5880 | AcceGen | 1 vial | Ask for price |
|
Description: Human GALNT13 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
|||
Human GALNT13 Protein Lysate 20ug |
|||
| IHUGALNT13PLLY20UG | Innovative research | each | EUR 213 |
|
Description: Human GALNT13 Protein Lysate 20ug |
|||
GALNT13 ELISA Kit (Human) (OKCA01432) |
|||
| OKCA01432 | Aviva Systems Biology | 96 Wells | EUR 1015.2 |
|
Description: Description of target: Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor. Has a much stronger activity than GALNT1 to transfer GalNAc to mucin peptides, such as Muc5Ac and Muc7. Able to glycosylate SDC3. May be responsible for the synthesis of Tn antigen in neuronal cells. ;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sanadwich ELISA;Sensitivity: 9.77 pg/mL |
|||
Galnt13 Peptide - C-terminal region |
|||
| MBS3234798-01mg | MyBiosource | 0.1mg | EUR 180 |
Galnt13 Peptide - C-terminal region |
|||
| MBS3234798-5x01mg | MyBiosource | 5x0.1mg | EUR 730 |
GALNT13 antibody - N-terminal region |
|||
| MBS3209842-01mL | MyBiosource | 0.1mL | EUR 455 |
GALNT13 antibody - N-terminal region |
|||
| MBS3209842-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
Galnt13 Antibody - C-terminal region |
|||
| MBS3209843-01mL | MyBiosource | 0.1mL | EUR 455 |
Galnt13 Antibody - C-terminal region |
|||
| MBS3209843-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
GALNT13 (NM_052917) Human Over-expression Lysate |
|||
| E45H13296-2 | EnoGene | each | EUR 395 |
GALNT13 (NM_052917) Human Over-expression Lysate |
|||
| LS114805 | BosterBio | 100ug | EUR 628 |
|
Description: Transient overexpression lysate of UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13) (GALNT13) |
|||
OCOA07001-20UG - GALNT13 Protein Lysate |
|||
| OCOA07001-20UG | Aviva Systems Biology | 20ug | EUR 169 |
GALNT13 (myc-DDK-tagged) - Human polypeptide N-acetylgalactosaminyltransferase 13 (GALNT13), transcript variant 2 |
|||
| RC238902 | Origene Technologies GmbH | 10 µg | Ask for price |
GALNT13 Over-expression Lysate Product |
|||
| GWB-3B60C7 | GenWay Biotech | 0.1 mg | Ask for price |
GALNT13 Antibody (Center) Blocking Peptide |
|||
| MBS9223241-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Galnt13 sgRNA CRISPR Lentivector set (Rat) |
|||
| K7420001 | ABM | 3 x 1.0 ug | EUR 406.8 |
